US IPO Week Ahead: een lege kalender en een rustige week voor de IPO-markt

US IPO Week Ahead: een lege kalender en een rustige week voor de IPO-markt

april 13, 2020 0 Door admin

Translating…


CBD Olie kan helpen bij ADHD. Lees hoe op MHBioShop.com


Huile de CBD peut aider avec TDAH. Visite HuileCBD.be


 

There are no IPOs scheduled for the week ahead.

The most likely April IPOs

Despite the encouraging market rally this past week, the Renaissance IPO Volatility Index is still about double the five-year average and few companies have filed, indicating the IPO market’s slow April will continue.

April’s headline IPO could come from grocery giant Albertsons Companies (ACI), which is benefiting from a surge in demand and low interest rates. With successful public debuts from Keros Therapeutics (NASDAQ:KROS) and Zentalis Pharmaceuticals (NASDAQ:ZNTL), the most likely IPO launches include several biotechs, such as oncology-focused Ayala Pharmaceuticals (AYLA) and ORIC Pharmaceuticals (ORIC), ENT biotech Lyra Therapeutics (LYRA), and CNS drug developer NLS Pharmaceutics (NLSP). Massive capital raises by biotech VCs also indicate investor optimism in the space.

4 Recent Biotech Filers in the IPO Pipeline

Issuer
Business

Deal
Size

File Date

Lead
Underwriter

Ayala Pharmaceuticals

$50M

03/06/2020

Citi

Phase 2 biotech developing small molecule therapies for aggressive cancers.

Lyra Therapeutics

$58M

03/06/2020

BofA

Phase 2 biotech targeting ear, nose, and throat diseases.

NLS Pharmaceutics

$40M

02/28/2020

Maxim Group

Developing controlled-release formulations of approved drugs for ADHD and narcolepsy.

ORIC Pharmaceuticals

$86M

02/28/2020

Roth Cap.

Phase 1 biotech developing small molecule therapies for treatment-resistant cancers.

One lock-up period will be expiring in the week ahead. On Tuesday, 4/14: BellRing Brands (NYSE:BRBR).

IPO Market Snapshot

The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 4/8/20, the Renaissance IPO Index was down 14.2% year-to-date, while the S&P 500 was down 14.9%. Renaissance Capital’s IPO ETF (NYSEARCA:IPO) tracks the index, and top ETF holdings include Uber (NYSE:UBER) and Spotify (NYSE:SPOT). The Renaissance International IPO Index was down 9.9% year-to-date, while the ACWX was down 21.7%. Renaissance Capital’s International IPO ETF (NYSEARCA:IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and Adyen.

Original post

Editor’s Note: The summary bullets for this article were chosen by Seeking Alpha editors.


CBD Olie kan helpen bij ADHD. Lees hoe op MHBioShop.com


Huile de CBD peut aider avec TDAH. Visite HuileCBD.be


 
Lees meer